Sex Selection of Human Spermatozoa
1 other identifier
interventional
2,000
1 country
1
Brief Summary
This study aims to demonstrate a reliable method of selecting gender specific sperm. X-bearing spermatozoa and Y-bearing spermatozoa will be identified from the density gradient layers. The selected gender specimen will then be utilized for assisted reproductive fertilization- in vitro fertilization or intrauterine insemination which are routine standard of care procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 6, 2013
CompletedFirst Submitted
Initial submission to the registry
August 11, 2022
CompletedFirst Posted
Study publicly available on registry
August 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
June 24, 2025
June 1, 2025
13.2 years
August 11, 2022
June 18, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Rate of gender bearing spermatozoa after 4-layer density gradient
8 years
Rate of embryos of the desired gender in couples
8 years
Rate of offspring of the desired gender in couples
8 years
Study Arms (1)
Sperm sorting
EXPERIMENTALSelection of gender specific spermatozoa using a multilayer density gradient
Interventions
Selection of gender specific spermatozoa using a multilayer density gradient solution
Eligibility Criteria
You may qualify if:
- Couples undergoing infertility treatment with IVF or insemination seeking gender specific offspring for medical and non medical reasons
You may not qualify if:
- Severe male factor
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Center for Reproductive Medicine- Weill Cornell Medicine
New York, New York, 10021, United States
Related Publications (1)
Cheung S, Elias R, Xie P, Rosenwaks Z, Palermo GD. A non-randomized clinical trial to determine the safety and efficacy of a novel sperm sex selection technique. PLoS One. 2023 Mar 22;18(3):e0282216. doi: 10.1371/journal.pone.0282216. eCollection 2023.
PMID: 36947521DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gianpiero Palermo, MD, PhD
Weill Medical College of Cornell University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 11, 2022
First Posted
August 15, 2022
Study Start
November 6, 2013
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2027
Last Updated
June 24, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share